
J&J continues settlement trend, resolves another Risperdal lawsuit one week before its trial
Feb. 22, 2017 – San Diego, CA − One week before a Risperdal gynecomastia trial was set to begin in Philadelphia, Janssen Pharmaceuticals settled the case for an undisclosed amount. The case...

Brazil stops sale of Essure pointing to numerous side effects
Feb. 21, 2017 -- San Diego, CA — In a move that is sure to spark hope among the thousands of Essure Advocates here in the United States, Brazil's national health...

MDL Panel widens scope of Taxotere litigation, concludes generic drug complaints are allowed
Feb. 20, 2017 – San Diego, CA —Taxotere hair loss lawsuits are steadily being filed in Louisiana federal court following a massive spike during the holiday season. The Taxotere multidistrict litigation...

Both parties agree to push back Xarelto bellwether trials again
Feb. 17, 2017 – San Diego, CA — Plaintiffs in the four lawsuits picked to be tried first in the Xarelto multidistrict litigation (MDL) will have to wait a little longer...

First Ethicon Physiomesh lawsuit to head to trial scheduled for 2018
Feb. 16, 2017 – San Diego, CA — Johnson & Johnson’s Ethicon Inc. will defend itself in the first Physiomesh lawsuit to go to trial next year. The trial is scheduled...

Hernia Mesh Complications: How to Submit Adverse Event Reports and Why You Should
Feb. 15, 2017 – San Diego, CA — Hernia mesh complications can occur long after the initial hernia repair surgery. This point was highlighted in a recent study, which found...

Government report on power morcellators highlights failures of FDA adverse event reporting
Feb. 14, 2017 – San Diego, CA — A new report from the Government Accountability Office (GAO) delves deep into the risks posed by power morcellators and exposes gaps within the...

DuPont agrees to $671 million settlement with plaintiffs injured by cancer-causing Teflon chemical
Feb. 13, 2017 – San Diego, CA — DuPont has agreed to pay more than $670 million in cash to settle thousands of lawsuits accusing the company of poisoning local water...

Xarelto maker stops latest trial early citing positive results
Feb. 10, 2017 – San Diego, CA — The results of the newest Xarelto clinical trial were so promising, Janssen Research & Development decided to end the trial early. Janssen is...

Elderly patients better off taking placebo in new Risperdal study
Feb. 9, 2017 – San Diego, CA — For elderly patients in palliative care, treating symptoms of delirium with the antipsychotic Risperdal may make some symptoms worse, a new study finds....
Categories
Recent post
- California Rideshare Accidents Involving Minors: What Parents Need to Understand
- Proving Distracted Driving in California Personal Injury Cases: Evidence That Strengthens Your Claim
- Rear-End Collisions in California: Why Fault Isn’t Always Clear
- The Long-Term Costs of TBIs and How California Personal Injury Attorneys Secure Compensation
- Dog Bite Injuries on Rental Properties: What California Tenants and Visitors Need to Know About Liability